BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 18026184)

  • 21. Characterizing genetic risk at known prostate cancer susceptibility loci in African Americans.
    Haiman CA; Chen GK; Blot WJ; Strom SS; Berndt SI; Kittles RA; Rybicki BA; Isaacs WB; Ingles SA; Stanford JL; Diver WR; Witte JS; Chanock SJ; Kolb S; Signorello LB; Yamamura Y; Neslund-Dudas C; Thun MJ; Murphy A; Casey G; Sheng X; Wan P; Pooler LC; Monroe KR; Waters KM; Le Marchand L; Kolonel LN; Stram DO; Henderson BE
    PLoS Genet; 2011 May; 7(5):e1001387. PubMed ID: 21637779
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression in human prostate of drug- and carcinogen-metabolizing enzymes: association with prostate cancer risk.
    Agúndez JA; Martínez C; Olivera M; Gallardo L; Ladero JM; Rosado C; Prados J; Rodriguez-Molina J; Resel L; Benítez J
    Br J Cancer; 1998 Nov; 78(10):1361-7. PubMed ID: 9823980
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between polymorphisms at N-acetyltransferase 1 (NAT1) & risk of oral leukoplakia & cancer.
    Majumder M; Ghosh S; Roy B
    Indian J Med Res; 2012 Oct; 136(4):605-13. PubMed ID: 23168701
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic variation in nucleotide excision repair pathway genes, pesticide exposure and prostate cancer risk.
    Barry KH; Koutros S; Andreotti G; Sandler DP; Burdette LA; Yeager M; Beane Freeman LE; Lubin JH; Ma X; Zheng T; Alavanja MC; Berndt SI
    Carcinogenesis; 2012 Feb; 33(2):331-7. PubMed ID: 22102698
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interactions among polymorphisms of NER genes prompt the risk of transplantation rejection.
    Wang BG; Lv Z; Xu Q; Liu YF
    Yi Chuan; 2017 Jan; 39(1):22-31. PubMed ID: 28115302
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A common nonsense mutation in EphB2 is associated with prostate cancer risk in African American men with a positive family history.
    Kittles RA; Baffoe-Bonnie AB; Moses TY; Robbins CM; Ahaghotu C; Huusko P; Pettaway C; Vijayakumar S; Bennett J; Hoke G; Mason T; Weinrich S; Trent JM; Collins FS; Mousses S; Bailey-Wilson J; Furbert-Harris P; Dunston G; Powell IJ; Carpten JD
    J Med Genet; 2006 Jun; 43(6):507-11. PubMed ID: 16155194
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Haplotype-based association studies of IGFBP1 and IGFBP3 with prostate and breast cancer risk: the multiethnic cohort.
    Cheng I; Penney KL; Stram DO; Le Marchand L; Giorgi E; Haiman CA; Kolonel LN; Pike M; Hirschhorn J; Henderson BE; Freedman ML
    Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1993-7. PubMed ID: 17035411
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Well-done meat consumption, NAT1 and NAT2 acetylator genotypes and prostate cancer risk: the multiethnic cohort study.
    Sharma S; Cao X; Wilkens LR; Yamamoto J; Lum-Jones A; Henderson BE; Kolonel LN; Le Marchand L
    Cancer Epidemiol Biomarkers Prev; 2010 Jul; 19(7):1866-70. PubMed ID: 20570911
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nucleotide excision repair gene polymorphisms and risk of advanced colorectal adenoma: XPC polymorphisms modify smoking-related risk.
    Huang WY; Berndt SI; Kang D; Chatterjee N; Chanock SJ; Yeager M; Welch R; Bresalier RS; Weissfeld JL; Hayes RB
    Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):306-11. PubMed ID: 16492920
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Variation in N-acetyltransferase 2 (NAT2), smoking and risk of prostate cancer in the Slovak population.
    Vilčková M; Jurečeková J; Dobrota D; Habalová V; Klimčáková L; Waczulíková I; Slezák P; Kliment J; Sivoňová MK
    Med Oncol; 2014 Jun; 31(6):987. PubMed ID: 24816842
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NAT1 and NAT2 genetic polymorphisms and environmental exposure as risk factors for oesophageal squamous cell carcinoma: a case-control study.
    Matejcic M; Vogelsang M; Wang Y; Iqbal Parker M
    BMC Cancer; 2015 Mar; 15():150. PubMed ID: 25886288
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sequence variation within the 5' regulatory regions of the vitamin D binding protein and receptor genes and prostate cancer risk.
    Kidd LC; Paltoo DN; Wang S; Chen W; Akereyeni F; Isaacs W; Ahaghotu C; Kittles R
    Prostate; 2005 Aug; 64(3):272-82. PubMed ID: 15717311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic variation in adiponectin (ADIPOQ) and the type 1 receptor (ADIPOR1), obesity and prostate cancer in African Americans.
    Beebe-Dimmer JL; Zuhlke KA; Ray AM; Lange EM; Cooney KA
    Prostate Cancer Prostatic Dis; 2010 Dec; 13(4):362-8. PubMed ID: 20697428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Xeroderma pigmentosum complementation group C single-nucleotide polymorphisms in the nucleotide excision repair pathway correlate with prolonged progression-free survival in advanced ovarian cancer.
    Fleming ND; Agadjanian H; Nassanian H; Miller CW; Orsulic S; Karlan BY; Walsh CS
    Cancer; 2012 Feb; 118(3):689-97. PubMed ID: 21751198
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prostate cancer susceptibility Loci identified on chromosome 12 in African Americans.
    Bonilla C; Hooker S; Mason T; Bock CH; Kittles RA
    PLoS One; 2011 Feb; 6(2):e16044. PubMed ID: 21358824
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ICAM gene cluster SNPs and prostate cancer risk in African Americans.
    Chen H; Hernandez W; Shriver MD; Ahaghotu CA; Kittles RA
    Hum Genet; 2006 Aug; 120(1):69-76. PubMed ID: 16733712
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking.
    Okkels H; Sigsgaard T; Wolf H; Autrup H
    Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):225-31. PubMed ID: 9107426
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic polymorphisms in CYP17, CYP3A4, CYP19A1, SRD5A2, IGF-1, and IGFBP-3 and prostate cancer risk in African-American men: the Flint Men's Health Study.
    Sarma AV; Dunn RL; Lange LA; Ray A; Wang Y; Lange EM; Cooney KA
    Prostate; 2008 Feb; 68(3):296-305. PubMed ID: 18163429
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Smoking and polymorphisms in xenobiotic metabolism and DNA repair genes are additive risk factors affecting bladder cancer in Northern Tunisia.
    Rouissi K; Ouerhani S; Hamrita B; Bougatef K; Marrakchi R; Cherif M; Ben Slama MR; Bouzouita M; Chebil M; Ben Ammar Elgaaied A
    Pathol Oncol Res; 2011 Dec; 17(4):879-86. PubMed ID: 21647780
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of susceptibility alleles in ELAC2/HPC2, RNASEL/HPC1, and MSR1 with prostate cancer severity in European American and African American men.
    Rennert H; Zeigler-Johnson CM; Addya K; Finley MJ; Walker AH; Spangler E; Leonard DG; Wein A; Malkowicz SB; Rebbeck TR
    Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):949-57. PubMed ID: 15824169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.